The 20 Best Gastroesophageal Junction Cancer Doctors Near Me

Julio Garcia-Aguilar is a Colorectal Surgeon practicing medicine in New York, New York. Dr. Garcia-Aguilar is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Ileostomy, and Colostomy. Dr. Garcia-Aguilar is currently accepting new patients.

Mokenge Malafa is a General Surgeon practicing medicine in Tampa, Florida. Dr. Malafa is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Adenoma, Pancreatectomy, and Small Bowel Resection. Dr. Malafa is currently accepting new patients.

Pamela Hodul is a General Surgeon practicing medicine in Tampa, Florida. Dr. Hodul is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Ampullary Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Hodul is currently accepting new patients.

Marwan Fakih is an Oncologist practicing medicine in Duarte, California. Dr. Fakih is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Liver Embolization, and Endoscopy.

Sarah Hoffe is a Radiation Oncologist practicing medicine in Tampa, Florida. Dr. Hoffe is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Anal Cancer, Esophageal Cancer, Lymphadenectomy, and Pancreaticoduodenectomy. Dr. Hoffe is currently accepting new patients.

Shishir Maithel is a Surgical Oncologist practicing medicine in Chicago, Illinois. Dr. Maithel is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Disease, Hepatectomy, and Pancreaticoduodenectomy. Dr. Maithel is board certified in American Board Of Surgery - Surgery (Certified). Dr. Maithel is currently accepting new patients.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Laheru is board certified in American Board Of Internal Medicine. Dr. Laheru is currently accepting new patients.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine. Dr. Azad is currently accepting new patients.

Ursina Teitelbaum is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Teitelbaum is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization. Dr. Teitelbaum is board certified in Hospice And Palliative Medicine, 2012 and Medical Oncology, 2006. Dr. Teitelbaum is currently accepting new patients.

Martin Weiser is a Colorectal Surgeon practicing medicine in New York, New York. Dr. Weiser is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Ileostomy, and Colostomy. Dr. Weiser is currently accepting new patients.

Timothy Pawlik is a Surgical Oncologist practicing medicine in Columbus, Ohio. Dr. Pawlik is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy. Dr. Pawlik is currently accepting new patients.

Thorvardur Halfdanarson is a Hematologist and an Oncologist practicing medicine in Rochester, Minnesota. Dr. Halfdanarson is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Hepatectomy. Dr. Halfdanarson is currently accepting new patients.

Jonathan Strosberg is an Oncologist practicing medicine in Tampa, Florida. Dr. Strosberg is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Liver Embolization, and Pancreaticoduodenectomy. Dr. Strosberg is currently accepting new patients.

Giuseppe Curigliano practices practicing medicine in Milan, Italy. Mr. Curigliano is rated as an Elite expert by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, Mastectomy, and Tissue Biopsy.

Wei Wang is a Psychiatrist practicing medicine in Englewood, New Jersey. Dr. Wang is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 84 other conditions, according to our data. Her clinical expertise encompasses Gallbladder Disease, Dementia, Ocular Hypertension (OHT), Bone Marrow Aspiration, and Endoscopy. Dr. Wang is currently accepting new patients.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Hepatectomy. Dr. Bergsland is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Bergsland is currently accepting new patients.

Denise Yardley is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Yardley is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Paget Disease of the Breast. Dr. Yardley is currently accepting new patients.

Blase Polite is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Polite is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Appendix Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Gastrostomy, and Bone Marrow Aspiration. Dr. Polite is board certified in Practicing Since2006 and Medical Oncology. Dr. Polite is currently accepting new patients.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine. Dr. Pishvaian is currently accepting new patients.

Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.